SCARICA IL MANUALE JBI PER LA SINTESI DELLE EVIDENZE “FREE” !

METODOLOGIA, REAL WORLD EVIDENCE

JBIMANUAL FOR EVIDENCE SYNTHESIS April 2021 JBI Manual for Evidence Synthesis Welcome to the JBI Manual for Evidence Synthesis JBI is an international evidence-based healthcare research organisation that works with 70+ Universities and Hospitals (known as the JBI Collaboration) around the world. The organisation focuses on improving health outcomes globally by producing and disseminating research…

UN NUOVO INIBITORE PER LA TERAPIA DELLA NASH DA GASTROENTEROLOGY: UN TRIAL

EPATOLOGIA, MEDICINA INTERNA, Senza categoria

TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial Rohit Loomba et al. Background & Aims Increased de novo lipogenesis creates excess intrahepatic fat and lipotoxins, propagating liver damage in nonalcoholic steatohepatitis. TVB-2640, a fatty acid synthase inhibitor, was designed to reduce excess liver fat and directly inhibit…

DA FANS AD OPIOIDI : FATTORI DI RISCHIO PER IL MAL DI SCHIENA. UNO STUDIO DI REAL-WORLD EVIDENCE DALLA CAMPANIA

MEDICINA INTERNA, REAL WORLD EVIDENCE

Predictors of Opioid Prescribing for Non-Malignant Low Back Pain in an Italian Primary Care Setting Simona Cammarota et al. This study explores which patient characteristics could affect the likelihood of starting low back pain (LBP) treatment with opioid analgesics vs. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in an Italian primary care setting. Through the computerized medical records…

PERCORSO DIAGNOSTICO E GESTIONALE DEL PAZIENTE CON NASH: UN “CLINICAL CARE PATHWAY” DA AGA

CIRROSI EPATICA, EPATOLOGIA, GASTROENTEROLOGIA, MEDICI DI FAMIGLIA, MEDICINA INTERNA, NUTRIZIONE

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease Fasiha Kanwal et al. Find AGA’s NASH Clinical Care Pathway App for iOS and Android mobile devices at nash.gastro.org. Scan this QR code to be taken directly to the website.Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting…

TRE GRAVI ERRORI O MITI SUL COVID -19. UN DOC “FREE” DAL REAL CENTRE DOPO UN ANNO DI EPIDEMIA

COVID19 - EVIDENCE, INTERNATIONAL SNAPSHOTS, MEDICI DI FAMIGLIA

REAL Centre. One year on Three myths about COVID-19 that the data proved wrong Data analysis (PDF version) • 23 March 2021 Holly Krelle, Charles Tallack About this article The charts in this analysis highlight three ‘myths’ that were prevalent at the very start of the pandemic. We use a common measure ‘years of life…